<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/archiving/3.0/archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Immunol</journal-id><journal-id journal-id-type="publisher-id">eji</journal-id><journal-title-group><journal-title>European Journal of Immunology</journal-title></journal-title-group><issn pub-type="ppub">0014-2980</issn><issn pub-type="epub">1521-4141</issn><publisher><publisher-name>WILEY-VCH Verlag</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1002/eji.200636362</article-id><article-categories><subj-group subj-group-type="heading"><subject>Innate immunity</subject></subj-group></article-categories><title-group><article-title>A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Barr</surname><given-names>Daniel P</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Reading</surname><given-names>Patrick C</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wojtasiak</surname><given-names>Magdalena</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Whitney</surname><given-names>Paul G</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Heath</surname><given-names>William R</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Carbone</surname><given-names>Francis R</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Brooks</surname><given-names>Andrew G</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib></contrib-group><aff id="au1"><label>1</label><institution>Department of Microbiology and Immunology, The University of Melbourne</institution><addr-line>Melbourne, Australia</addr-line></aff><aff id="au2"><label>1</label><institution>Division of Immunology, The Walter and Eliza Hall Institute of Medical Research</institution><addr-line>Melbourne, Australia</addr-line></aff><author-notes><corresp id="cor1">Correspondence: Dr. Andrew G. Brooks, Department of Microbiology and Immunology, The University of Melbourne, Melbourne, 3010 Victoria, Australia, Fax: +61-3-9347-1540 e-mail: <email>agbrooks@unimelb.edu.au</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2007</year></pub-date><volume>37</volume><issue>5</issue><fpage>1334</fpage><lpage>1342</lpage><history><date date-type="received"><day>09</day><month>6</month><year>2006</year></date><date date-type="rev-recd"><day>10</day><month>1</month><year>2007</year></date><date date-type="accepted"><day>16</day><month>2</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 WILEY-VCH Verlag GmbH &#x00026; Co. KGaA, Weinheim</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p></license></permissions><abstract><p>Natural killer (NK) cells play a crucial role in the initial response to viral infections but the mechanisms controlling their activation are unclear. We show a rapid and transient activation of NK cells that results in the production of IFN-&#x003b3; immediately following infection with herpes simplex virus type 1 (HSV-1). Activation of NK cells leading to synthesis of IFN-&#x003b3; was not mediated by a direct interaction with virus but required the presence of additional cell types and was largely dependent on the cytokine IL-18, but not IL-12. HSV-1-induced IFN-&#x003b3; expression by NK cells <italic>in vitro</italic> was impaired in spleen cultures depleted of CD11c<sup>+</sup> cells. Conversely, coculture of NK cells with virus-exposed conventional DC or plasmacytoid (p)DC restored the production of IFN-&#x003b3;, indicating that multiple DC subsets could mediate NK cell activation. While conventional DC populations stimulated NK cells independently of IL-18, they were less effective than pDC in promoting NK cell IFN-&#x003b3; expression. In contrast, the potent stimulation of NK cells by pDC was dependent on IL-18 as pDC from IL-18-deficient mice only activated a similar proportion of NK cells as conventional DC. These data identify IL-18 as a crucial factor for pDC-mediated NK cell regulation.</p></abstract><kwd-group><kwd>Cytokines</kwd><kwd>Dendritic cells</kwd><kwd>HSV-1</kwd><kwd>NK cells</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Natural killer cells are critical components of the innate immune system and have key roles in early immune responses to various tumours and viruses <xref ref-type="bibr" rid="b1">1</xref>. While the interaction between NK receptors and ligands expressed on the surface of target cells has been shown to modulate the effector function of NK cells <xref ref-type="bibr" rid="b2">2</xref>, <xref ref-type="bibr" rid="b3">3</xref> following infection, pro-inflammatory cytokines such as IL-12 and IL-18 are thought to regulate NK cell activation <xref ref-type="bibr" rid="b4">4</xref>&#x02013;<xref ref-type="bibr" rid="b6">6</xref>.</p><p>Microbial products such as <italic>Escherichia coli</italic> lipopolysaccharide and unmethylated CpG dinucleotides can induce IL-12 secretion by macrophages and bone marrow-derived DC <xref ref-type="bibr" rid="b7">7</xref>&#x02013;<xref ref-type="bibr" rid="b10">10</xref>. Similarly, distinct lineages of DC isolated from mice can produce IL-12 <xref ref-type="bibr" rid="b11">11</xref>. In particular, conventional CD8&#x003b1;<sup>+</sup> DC and plasmacytoid DC (pDC) populations have been shown to elaborate IL-12 following viral infection or culture with a variety of microbiological stimuli <xref ref-type="bibr" rid="b12">12</xref>&#x02013;<xref ref-type="bibr" rid="b16">16</xref>.</p><p>Biologically active IL-18 can be rapidly produced by cells following the proteolytic cleavage of an inactive pro-IL-18 precursor <xref ref-type="bibr" rid="b17">17</xref>, <xref ref-type="bibr" rid="b18">18</xref>, which appears to accumulate within cells such as DC <xref ref-type="bibr" rid="b19">19</xref>. While DC are an important source of IL-18 <xref ref-type="bibr" rid="b20">20</xref>, <xref ref-type="bibr" rid="b21">21</xref>, it can also be expressed by a variety of other cells including astrocytes and microglia <xref ref-type="bibr" rid="b22">22</xref>, keratinocytes <xref ref-type="bibr" rid="b23">23</xref>, epithelial cells <xref ref-type="bibr" rid="b24">24</xref>, adipocytes <xref ref-type="bibr" rid="b25">25</xref> and cells of the adrenal gland and kidneys <xref ref-type="bibr" rid="b26">26</xref>, <xref ref-type="bibr" rid="b27">27</xref>. IL-18 has pleiotropic effects that depend to some extent on the cytokine milieu and acts in concert with IL-12 to induce IFN-&#x003b3; production by NK cells <xref ref-type="bibr" rid="b28">28</xref>&#x02013;<xref ref-type="bibr" rid="b30">30</xref>.</p><p>Numerous studies using neutralising antibodies or animals with targeted gene disruptions suggest that production of both IL-12 and IL-18 is required for control of certain bacterial, fungal, protozoan and viral pathogens in mouse models of infection <xref ref-type="bibr" rid="b31">31</xref>, <xref ref-type="bibr" rid="b32">32</xref>. However, production of both IL-12 and IL-18 during immune responses is not always required. IL-18-deficient mice but not IL-12-deficient mice are susceptible to pneumococcal infection <xref ref-type="bibr" rid="b33">33</xref>. Conversely, while both cytokines collaborate for the induction of splenic NK cell IFN-&#x003b3; responses following murine cytomegalovirus (MCMV) infection, only IL-12 is required for hepatic NK cell activity <xref ref-type="bibr" rid="b34">34</xref>. Here, we show that splenic NK cells rapidly produce IFN-&#x003b3; following HSV-1 infection <italic>via</italic> a mechanism largely dependent on the presence of IL-18, but not IL-12. Moreover, while both conventional DC and pDC have the capacity to activate NK cells in response to HSV-1, we identify a role for IL-18 in the potent pDC-dependent stimulation of IFN-&#x003b3; production by NK cells.</p></sec><sec><title>Results</title><sec><title>The <italic>in vivo</italic> NK cell response following HSV-1 infection is rapid and transient</title><p>Depletion of NK cells prior to infection with HSV-1 can result in elevated viral replication and increased morbidity and mortality <xref ref-type="bibr" rid="b35">35</xref>&#x02013;<xref ref-type="bibr" rid="b37">37</xref>. However, the mechanisms by which HSV-1 infection induces NK cell activation <italic>in vivo</italic> are unclear. We made use of an intravenous model of HSV-1 infection in C57BL/6 (B6) mice to better define the events that result in NK cell activation. Splenocytes isolated from either na&#x000ef;ve mice, mock-infected mice or mice infected 6 h earlier with 10<sup>6</sup> PFU of HSV-1 were cultured for 4 h in the presence of Brefeldin A and the production of IFN-&#x003b3; by NK cells was assessed by flow cytometry. Few CD3<sup>&#x02013;</sup> NK1.1<sup>+</sup> NK cells from na&#x000ef;e or mock-infected mice expressed IFN-&#x003b3; (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>). In contrast, there was a marked increase in the proportion of NK cells that produced IFN-&#x003b3; 6 h post-infection with HSV-1. This response was dose dependent, with greater than 60% of splenic NK cells staining positively for IFN-&#x003b3; following inoculation with 10<sup>7</sup> PFU (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>) but not dependent on viral replication since a similar proportion of activated splenic NK cells was observed when mice were inoculated with UV-inactivated HSV-1 (<xref ref-type="fig" rid="fig01">Fig. 1C</xref>).</p><fig id="fig01" position="float"><label>Figure 1</label><caption><p>Immediate activation of NK cells following intravenous infection with HSV-1. Spleens were obtained from na&#x000ef;e B6 mice or 6 h after B6 mice were injected intravenously with (A) Vero cell lysate (Mock) or 10<sup>6</sup> PFU of HSV-1, (B) increasing doses of HSV-1, (C) Vero cell lysate (Mock), 10<sup>6</sup> PFU of HSV-1 or an equivalent amount of UV-inactivated HSV-1, and the proportion of NK cells producing IFN-&#x003b3; determined by flow cytometry. (D) Spleens were obtained from na&#x000ef;e, mock-infected (Vero cell lysate) or HSV-1-infected (10<sup>6</sup> PFU) mice at the indicated times post-infection and the proportion of NK cells producing IFN-&#x003b3; determined by flow cytometry. Data in panel (A) show representative dot plots of IFN-&#x003b3; production by NK cells, and have been gated on CD3&#x003b5;<sup>&#x02013;</sup> NK1.1<sup>+</sup> lymphocytes. Data in panels (B) and (C) show the mean proportion of NK cells producing IFN-&#x003b3; (&#x000b1; SD) and are representative of three independent experiments. Data in panel (D) show the mean proportion of NK cells producing IFN-&#x003b3; (&#x000b1; SE) from three independent experiments</p></caption><graphic xlink:href="eji0037-1334-f1"/></fig><p>To better understand the kinetics of NK cell activation following HSV-1 infection, the production of IFN-&#x003b3; by splenic NK cells was assessed at various times up to 24 h post-infection (<xref ref-type="fig" rid="fig01">Fig. 1D</xref>). IFN-&#x003b3; production was observed as early as 2 h post-infection, peaking at 6 h post-infection before declining to near background levels by 24 h. The kinetics of other parameters that are characteristic of activated NK cells was also assessed. The expression of CD69 and the capacity to lyse the NK cell-sensitive target cell YAC-1 were both increased over na&#x000ef;e and mock-infected controls as early as 6 h post-infection with HSV-1 (<xref ref-type="fig" rid="fig02">Fig. 2</xref>). In contrast to the IFN-&#x003b3; response, maximal cytotoxicity and CD69 expression on NK cells was observed 1 day post-infection. Moreover, while CD69 expression returned to levels observed in na&#x000ef;e mice by day 3, the ability of splenocytes to lyse YAC-1 targets remained elevated until 5 days post-infection (<xref ref-type="fig" rid="fig02">Fig. 2B and C</xref>).</p><fig id="fig02" position="float"><label>Figure 2</label><caption><p>The NK cell response to HSV-1 is characterized by IFN-&#x003b3; production, CD69 expression and increased YAC-1 cytolysis. Splenocytes were prepared from na&#x000ef;e (shaded column), mock-infected (unfilled columns) and HSV-1-infected (10<sup>6</sup> PFU, filled columns) mice at 6 h and 1, 3, 5 and 7 days post-infection. Cells were stained with anti-NK1.1-FITC and anti-CD3&#x003b5;-APC and the expression of (A) intracellular IFN-&#x003b3; and (B) cell surface CD69 by NK cells was assessed by flow cytometry. (C) Spleen cells were incubated with <sup>51</sup>Cr-labeled targets at an effector to target ratio of 100:1 and specific lysis was determined. Columns represent mean &#x000b1; SD of three mice at each time point. Data are representative of two independent experiments.</p></caption><graphic xlink:href="eji0037-1334-f2"/></fig></sec><sec><title>Crucial role of IL-18 for NK cell IFN-&#x003b3; expression following HSV-1 infection</title><p>IL-12 and IL-18 have been shown to activate the synthesis of IFN-&#x003b3; by NK cells <xref ref-type="bibr" rid="b28">28</xref>&#x02013;<xref ref-type="bibr" rid="b30">30</xref>, <xref ref-type="bibr" rid="b38">38</xref>, <xref ref-type="bibr" rid="b39">39</xref>. Therefore we assessed the contributions of IL-12 and IL-18 to the rapid activation of NK cells following infection with HSV-1 using mice lacking either IL-12p40 (B6.IL-12<sup>&#x02013;/&#x02013;</sup>) or IL-18 (B6.IL-18<sup>&#x02013;/&#x02013;</sup>). Mice were infected with HSV-1 and 6 h later the production of IFN-&#x003b3; by NK cells was determined by flow cytometry. NK cells from B6 and B6.IL-12<sup>&#x02013;/&#x02013;</sup> mice responded to HSV-1 infection, with &#x0223c;14% of splenic NK cells expressing IFN-&#x003b3; in both strains (<xref ref-type="fig" rid="fig03">Fig. 3A</xref>). This response was significantly reduced in IL-18-deficient mice with &#x0223c;4% of NK cells staining positive for IFN-&#x003b3; protein (<italic>p</italic> &#x0003c;0.001 compared to B6 or B6.IL-12<sup>&#x02013;/&#x02013;</sup> mice).</p><fig id="fig03" position="float"><label>Figure 3</label><caption><p>Rapid synthesis of IFN-&#x003b3; by NK cells in response to HSV-1 infection is dependent on IL-18 <italic>in vivo</italic>. Splenocytes were prepared from B6, B6.IL-12<sup>&#x02013;/&#x02013;</sup> and B6.IL-18<sup>&#x02013;/&#x02013;</sup> mice that were na&#x000ef;e (unfilled columns) or infected (A) 6 h, or (B, C) 24 h earlier with 10<sup>6</sup> PFU of HSV-1 (filled columns). (A) Cells were incubated for 4 h in Brefeldin A and then stained with mAb specific for NK1.1, CD3&#x003b5; and IFN-&#x003b3;. The proportion of IFN-&#x003b3;<sup>+</sup> NK cells was subsequently determined by flow cytometry. Columns represent mean &#x000b1; SD of five mice. Data are representative of at least three independent experiments. (B) Cells were stained with mAb specific for NK1.1, CD3&#x003b5; and CD69. The expression of CD69 by NK cells was subsequently determined by flow cytometry. Columns represent mean &#x000b1; SD of four mice. Data are representative of three independent experiments. (C) Spleen cells were incubated with <sup>51</sup>Cr-labeled targets at an effector to target ratio of 100:1 and specific lysis determined. Columns represent mean &#x000b1; SE of eight mice from two independent experiments. Statistical significance comparing results from infected animals is indicated.</p></caption><graphic xlink:href="eji0037-1334-f3"/></fig><p>To further examine the potential roles of IL-12 or IL-18 in the induction of NK cell activation after infection, we also assessed the expression of CD69 by NK cells and lysis of the NK cell-sensitive YAC-1 target cells by splenocytes from cytokine-deficient mice 1 day post-infection with 10<sup>6</sup> PFU of HSV-1. In contrast to the defect in the production of IFN-&#x003b3; observed in B6.IL-18<sup>&#x02013;/&#x02013;</sup> mice, the induction of both CD69 and cytotoxicity by NK cells were similar to that observed in both B6 and B6.IL-12<sup>&#x02013;/&#x02013;</sup> mice (<xref ref-type="fig" rid="fig03">Fig. 3B and C</xref>). Thus, while IL-12 appeared dispensable for NK cell activation in response to infection with HSV-1, these data demonstrated a role for IL-18 in the immediate and transient production of IFN-&#x003b3; by NK cells following HSV-1 infection <italic>in vivo</italic>.</p><p>To further dissect the mechanisms regulating the rapid and transient production of IFN-&#x003b3; by NK cells, we assessed the ability of HSV-1 to stimulate NK cells <italic>in vitro</italic>. As observed following <italic>in vivo</italic> infection, the addition of HSV-1 to B6 splenocytes rapidly activated NK cells with &#x0223c;21% of CD3&#x003b5;<sup>&#x02013;</sup> NK1.1<sup>+</sup> cells producing IFN-&#x003b3; by 8 h (<xref ref-type="fig" rid="fig04">Fig. 4A</xref>). The production of IFN-&#x003b3; was dependent on the addition of virus as few NK cells produced IFN-&#x003b3; when treated with a mock inoculum that lacked HSV-1. Furthermore, NK cell activation <italic>in vitro</italic> was not dependent on viral replication as the addition of UV-inactivated HSV-1 to splenocyte cultures also stimulated the production of IFN-&#x003b3; by NK cells (data not shown).</p><fig id="fig04" position="float"><label>Figure 4</label><caption><p>Crucial role of IL-18 for HSV-1-induced IFN-&#x003b3; production by NK cells. (A) Splenocytes from na&#x000ef;e mice were cultured for 8 h with Vero cell lysate (Mock) or 10<sup>6</sup> PFU of HSV-1. Cells were then cultured in Brefeldin A for 4 h, stained and the proportion of IFN-&#x003b3;<sup>+</sup> NK cells determined by flow cytometry. Representative histograms showing IFN-&#x003b3; production after gating on CD3&#x003b5;<sup>&#x02013;</sup> NK1.1<sup>+</sup> cells. (B) The proportion of IFN-&#x003b3;<sup>+</sup> NK cells in cultures of B6 (diamonds), B6.IL-12<sup>&#x02013;/&#x02013;</sup> (squares) and B6.IL-18<sup>&#x02013;/&#x02013;</sup> (triangles) splenocytes after incubation with increasing doses of HSV-1. (C) Purified B6.CD45.1 NK cells (5 &#x000d7; 10<sup>4</sup>) were cocultured with 10<sup>6</sup> CD45.1<sup>&#x02013;</sup> B6, B6.IL-12<sup>&#x02013;/&#x02013;</sup> or B6.IL-18<sup>&#x02013;/&#x02013;</sup> splenocytes with Mock inoculum or HSV-1. Values represent the proportion of CD45.1<sup>+</sup> IFN-&#x003b3;<sup>+</sup> events. (D) IFN-&#x003b3; production by NK cells in B6 (diamonds) and B6.IL-18<sup>&#x02013;/&#x02013;</sup> (triangles) splenocytes induced by Mock inoculum (unfilled) or HSV-1 (filled) in the presence of the indicated concentrations of recombinant mouse (rm)IL-18. (B&#x02013;D) Data show mean &#x000b1; SD from triplicate cultures. All data are representative of at least three independent experiments.</p></caption><graphic xlink:href="eji0037-1334-f4"/></fig><p>To confirm a role for IL-18 in the rapid induction of IFN-&#x003b3; production by NK cells, we assessed the ability of splenic NK cells from B6, B6.IL-18<sup>&#x02013;/&#x02013;</sup> and B6.IL-12<sup>&#x02013;/&#x02013;</sup> mice to respond to HSV-1 <italic>in vitro</italic>. Few NK cells produced IFN-&#x003b3; after culture with a mock inoculum, regardless of genetic background (<xref ref-type="fig" rid="fig04">Fig. 4B</xref>). The proportion of NK cells from B6.IL-12<sup>&#x02013;/&#x02013;</sup> splenocytes that produced IFN-&#x003b3; following the addition of HSV-1 was almost identical to the response observed by NK cells from B6 animals. In contrast, the proportion of NK cells that produced IFN-&#x003b3; from B6.IL-18<sup>&#x02013;/&#x02013;</sup> splenocytes did not exceed 10% even when 10<sup>7</sup> PFU of virus was added to cultures.</p><p>The poor response of NK cells from IL-18-deficient mice suggested that this cytokine is required for optimal NK cell IFN-&#x003b3; responses following HSV-1 infection. Alternatively, the impaired response may have resulted from an intrinsic NK cell defect due to their development in the absence of IL-18. To discriminate between these possibilities, congeneically-marked NK cells were purified from B6.CD45.1 mice and mixed with either B6, B6.IL-12<sup>&#x02013;/&#x02013;</sup> or B6.IL-18<sup>&#x02013;/&#x02013;</sup> splenocytes (all CD45.1<sup>&#x02013;</sup>) and stimulated by the addition of HSV-1 (<xref ref-type="fig" rid="fig04">Fig. 4C</xref>). Cells were then stained with anti-CD45.1 mAb and the proportion of CD45.1<sup>+</sup> cells (<italic>i.e</italic>. wild-type NK cells) expressing intracellular IFN-&#x003b3; was assessed. In the absence of HSV-1, few CD45.1<sup>+</sup> NK cells added to CD45.1<sup>&#x02013;</sup> splenocyte cultures produced IFN-&#x003b3;. In contrast, IFN-&#x003b3; expression was evident in NK cells cocultured with HSV-1 and B6 (&#x0223c;20%) or B6.IL-12<sup>&#x02013;/&#x02013;</sup> (&#x0223c;25%) splenocytes. However, there was a marked reduction in the proportion of IFN-&#x003b3;<sup>+</sup> CD45.1<sup>+</sup> NK cells (&#x0223c;9%) after coculture with IL-18-deficient splenocytes. Thus, the IFN-&#x003b3; response of B6-derived NK cells to HSV-1 is defective when these cells are cultured with B6.IL-18<sup>&#x02013;/&#x02013;</sup> splenocytes.</p><p>We then assessed the ability of exogenous IL-18 to reverse the defective NK cell response observed in IL-18-deficient splenocytes. Again, in the absence of exogenous IL-18, the proportion of IFN-&#x003b3;-producing NK cells from cultures of IL-18-deficient splenocytes stimulated with HSV-1 was significantly reduced as compared to B6 splenocytes (<xref ref-type="fig" rid="fig04">Fig. 4D</xref>). Importantly, the addition of both virus and recombinant IL-18 to splenocytes from B6.IL-18<sup>&#x02013;/&#x02013;</sup> mice restored NK cell activation to similar levels observed for B6 splenocytes. Togethe, the data suggests that the impaired NK cell response in IL-18-deficient animals was not due to NK cell dysfunction but that IL-18 plays a crucial role in the production of IFN-&#x003b3; by NK cells immediately following HSV-1 infection.</p></sec><sec><title>HSV-1-induced IFN-&#x003b3; production is not due to direct recognition of virus by NK cells</title><p>Although the <italic>in vivo</italic> and <italic>in vitro</italic> IFN-&#x003b3; response of NK cells to HSV-1 occurred with remarkable rapidity, it was markedly dependent on IL-18. This suggested that activation of NK cells was not the result of a direct interaction of NK cells with HSV-1 but rather was dependent on other cell types that could act as a source of IL-18. To confirm that HSV-1-induced IFN-&#x003b3; production by NK cells required additional cells either as a source of cytokine or to provide crucial cell-to-cell interactions, NK cells were purified from B6.CD45.1 mice (CD45.1<sup>+</sup>) by cell sorting and assessed for their ability to produce IFN-&#x003b3; following incubation with HSV-1 alone or HSV-1 in the presence of congenically marked splenocytes. While purified NK cells did not respond following the addition of HSV-1, a high proportion of IFN-&#x003b3;<sup>+</sup> NK cells were observed following culture with both HSV-1 and congeneic splenocytes (<xref ref-type="fig" rid="fig05">Fig. 5</xref>). Therefore, the rapid production of IFN-&#x003b3; is not induced by a direct interaction between the virus and NK cells but requires the presence of other cell types that may provide crucial cellular interactions or secrete soluble factors including IL-18.</p><fig id="fig05" position="float"><label>Figure 5</label><caption><p>HSV-1-induced activation of NK cells <italic>in vitro</italic> requires other cell types. Purified CD45.1<sup>+</sup> NK cells (5 &#x000d7; 10<sup>4</sup>) were cultured for 8 h with Vero cell lysate (Mock) or with 10<sup>6</sup> PFU HSV-1 in the presence or absence of 10<sup>6</sup> B6 splenocytes (CD45.1<sup>&#x02013;</sup>). After incubation in Brefeldin A for an additional 4 h, cells were labelled with anti-CD45.1 to identify purified NK cells and then assessed for IFN-&#x003b3; production. Values represent the proportion of CD45.1<sup>+</sup> IFN-&#x003b3;<sup>+</sup> events and are representative of at least three experiments.</p></caption><graphic xlink:href="eji0037-1334-f5"/></fig></sec><sec><title>DC regulate NK cell IFN-&#x003b3; synthesis in response to HSV-1</title><p>Given that HSV-1-dependent stimulation of IFN-&#x003b3; production required the presence of additional cells found in the spleen, and that a number of DC populations have been implicated in the activation of NK cell responses to viral pathogens <xref ref-type="bibr" rid="b7">7</xref>, <xref ref-type="bibr" rid="b40">40</xref>, we hypothesised that DC could mediate HSV-1-induced NK cell activation. Consequently, we wished to determine if freshly isolated DC could promote NK cell IFN-&#x003b3; production in response to HSV-1 <italic>via</italic> an IL-18-dependent mechanism. T cells from B6 mice or splenic DC (CD11c<sup>+</sup> F4/80<sup>&#x02013;</sup> low-density cells; <xref ref-type="fig" rid="fig06">Fig. 6A</xref> insert) from B6, B6.IL-12<sup>&#x02013;/&#x02013;</sup> and B6.IL-18<sup>&#x02013;/&#x02013;</sup> mice were isolated by cell sorting and assessed for their ability to stimulate IFN-&#x003b3; production by purified NK cells <italic>in vitro</italic>. Little evidence of NK cell activation was observed following culture of NK cells alone or with purified T cells in the presence of HSV-1 or mock inoculum (<xref ref-type="fig" rid="fig06">Fig. 6A</xref>). In contrast, DC from B6 and B6.IL-12<sup>&#x02013;/&#x02013;</sup> mice stimulated &#x0223c;38% and &#x0223c;33% of NK cells to produce IFN-&#x003b3; respectively when cultured in the presence of HSV-1. However, there was a significant impairment in the HSV-1-induced activation of purified NK cells following incubation with DC from B6.IL-18<sup>&#x02013;/&#x02013;</sup> mice, with only &#x0223c;17% of the cells responding. The data suggest that DC-derived IL-18 is important for the rapid production of IFN-&#x003b3; by NK cells following HSV-1 infection.</p><fig id="fig06" position="float"><label>Figure 6</label><caption><p>DC-derived IL-18 regulates HSV-1-induced NK cell activation. (A) Splenic DC were purified from B6, B6.IL-12<sup>&#x02013;/&#x02013;</sup> and B6.IL-18<sup>&#x02013;/&#x02013;</sup> mice by cell sorting (insert) and incubated with purified NK cells (1 &#x000d7; 10<sup>4</sup>) with 10<sup>6</sup> PFU HSV-1 (filled columns) or Vero cell lysate (unfilled columns). Data are shown as mean &#x000b1; SE. Statistical significance comparing results B6 DC to cytokine-deficient DC is indicated (n.s., not significant; *<italic>p</italic> 0.05). (B) Splenocytes from B6 mice or splenocytes depleted of CD11c-positive cells were cultured in the presence or absence of HSV-1 and the proportion of NK cells producing IFN-&#x003b3; determined (mean &#x000b1; SD) Statistical significance is indicated (*<italic>p</italic> &#x0003c;0.05). (C) Purified B6.CD45.1 NK cells were cocultured with CD11c-depleted and non-depleted splenocytes from B6 and B6.IL-12<sup>&#x02013;/&#x02013;</sup> mice in the presence of HSV-1 and then stained with anti-CD45.1 and anti-IFN-&#x003b3;. Values represent the proportion of IFN-&#x003b3;<sup>+</sup> CD45.1<sup>+</sup> NK cells determined by flow cytometry.</p></caption><graphic xlink:href="eji0037-1334-f6"/></fig><p>To further confirm a role for DC in mediating the HSV-1-induced production of IFN-&#x003b3; by NK cells, na&#x000ef;e B6 splenocytes were stained with anti-CD11c mAb and CD11c<sup>+</sup> cells were depleted from spleen cell preparations using cell sorting. Following 8 h culture in mock inoculum or HSV-1, the proportion of IFN-&#x003b3;<sup>+</sup> NK cells in CD11c-depleted cultures was compared to cultures that had been cell sorted without the depletion of CD11c<sup>+</sup> cells. As shown in <xref ref-type="fig" rid="fig06">Fig. 6B</xref>, while few NK cells produced IFN-&#x003b3; after 8 h culture in mock inoculum, coculture of non-depleted splenocytes with HSV-1 stimulated IFN-&#x003b3; production by &#x0223c;20% of the NK cells. In contrast, the depletion of CD11c<sup>+</sup> cells from splenocyte cultures significantly reduced the proportion of NK cells that produced IFN-&#x003b3; in response to HSV-1 to &#x0223c;13%.</p><p>The CD11c antigen can be expressed on cell types other than DC, including NK cells <xref ref-type="bibr" rid="b41">41</xref>. To ensure that the impaired activation of NK cells in CD11c-depleted spleen cultures was not due to the selective depletion of CD11c<sup>+</sup> NK cells, purified congeneically marked NK cells from B6.CD45.1 mice were cocultured either with non-depleted or CD11c-depleted splenocytes (both CD45.1<sup>&#x02013;</sup>) and then stimulated with HSV-1. Cells were then stained with anti-CD45.1 mAb and the proportion of CD45.1<sup>+</sup> NK cells expressing intracellular IFN-&#x003b3; was assessed. Again, the percentage of IFN-&#x003b3;<sup>+</sup> CD45.1<sup>+</sup> NK cells after coculture with CD11c-depleted splenocytes was decreased as compared to cultures that contained DC (<xref ref-type="fig" rid="fig06">Fig. 6C</xref>).</p><p>Whilst these studies confirm a role for DC in the rapid production of IFN-&#x003b3; by NK cells following exposure to HSV-1, they also highlight the ability of splenocytes of non-DC origin to mediate NK cell activation. No differences were noted in the ability of CD11c-depleted splenocytes from B6 and B6.IL-12<sup>&#x02013;/&#x02013;</sup> mice to induce IFN-&#x003b3; production by NK cells (<xref ref-type="fig" rid="fig06">Fig. 6C</xref>). Together, these data indicate that DC and cells of non-DC origin can activate NK cells after exposure to HSV-1, and that IL-12 is not required for these responses.</p></sec><sec><title>HSV-1-stimulated plasmacytoid DC, but not conventional DC, activate NK cells <italic>via</italic> IL-18</title><p>Numerous studies have demonstrated that there are a number of distinct populations of splenic DC (reviewed in <xref ref-type="bibr" rid="b11">11</xref>). To identify which of these populations played a role in HSV-1-induced activation of NK cells, CD11c<sup>+</sup> DC were purified from the spleens of B6, B6.IL-12<sup>&#x02013;/&#x02013;</sup> and B6.IL-18<sup>&#x02013;/&#x02013;</sup> animals, separated into subsets based on the expression of CD8&#x003b1; and CD45RA and directly assessed for their capacity to stimulate IFN-&#x003b3; production by NK cells from B6 mice. DC were sorted into pDC (CD45RA<sup>+</sup>) and conventional DC (CD45RA<sup>&#x02013;</sup>), the latter of which were further separated into CD8&#x003b1;<sup>&#x02013;</sup> (double negative, DN DC) and CD8&#x003b1;<sup>+</sup> (CD8&#x003b1;<sup>+</sup> DC) (<xref ref-type="fig" rid="fig07">Fig. 7A</xref>). Again, few NK cells produced IFN-&#x003b3; following culture alone or with purified B6 T cells regardless of whether HSV-1 was present or not (data not shown). Similarly, in the absence of HSV-1, coculture of NK cells with purified DC subsets did not stimulate the production of IFN-&#x003b3; regardless of genetic background (<xref ref-type="fig" rid="fig07">Fig. 7B&#x02013;D</xref>). In contrast, virus-exposed CD8&#x003b1;<sup>+</sup> DC obtained from B6 mice stimulated &#x0223c;21% of NK cells to synthesize IFN-&#x003b3; (<xref ref-type="fig" rid="fig07">Fig. 7B</xref>). CD8&#x003b1;<sup>+</sup> DC isolated from either B6.IL-12<sup>&#x02013;/&#x02013;</sup> or B6.IL-18<sup>&#x02013;/&#x02013;</sup> animals stimulated a similar proportion of NK cells to produce IFN-&#x003b3; in the presence of HSV-1 (<xref ref-type="fig" rid="fig07">Fig. 7B</xref>). Purified DN DC from B6, B6.IL-12<sup>&#x02013;/&#x02013;</sup> or B6.IL-18<sup>&#x02013;/&#x02013;</sup> were also equally effective in their ability to stimulate IFN-&#x003b3; production by NK cells in the presence of HSV-1 (<xref ref-type="fig" rid="fig07">Fig. 7C</xref>).</p><fig id="fig07" position="float"><label>Figure 7</label><caption><p>HSV-1-induced NK cell activation is mediated by multiple DC subsets. DC from na&#x000ef;e B6, B6.IL-12<sup>&#x02013;/&#x02013;</sup> and B6.IL-18<sup>&#x02013;/&#x02013;</sup> mice were enriched from splenocytes and stained with mAb specific for CD11c, CD8&#x003b1; and CD45RA. (A) Representative dot plot of CD11c<sup>+</sup> cells from a B6 animal analysed for expression of CD8&#x003b1; and CD45RA. DC subsets were purified by sorting of CD11c<sup>+</sup> splenocytes to obtain CD8&#x003b1;<sup>&#x02013;</sup> CD45RA<sup>&#x02013;</sup> (DN DC), CD8&#x003b1;<sup>+</sup> CD45RA<sup>&#x02013;</sup> (CD8&#x003b1;<sup>+</sup> DC) or CD45RA<sup>+</sup> (pDC). Purified NK cells (1 &#x000d7; 10<sup>4</sup>) were incubated with (5 &#x000d7; 10<sup>4</sup>) purified (B) CD8&#x003b1;<sup>+</sup> DC, (C) DN DC, or (D) pDC subsets in the presence of 10<sup>6</sup> PFU HSV-1 (filled columns) or Vero cell lysate (unfilled columns) for 6 to 8 h. Following incubation in Brefeldin A for an additional 4 h, cells were stained with anti-NK1.1 and anti-TCR&#x003b2;. Cells were then fixed, permeabilised and stained for intracellular IFN-&#x003b3;, and the proportion of NK cells that expressed IFN-&#x003b3; determined by flow cytometry. The proportion of IFN-&#x003b3;<sup>+</sup> NK cells are expressed as mean &#x000b1; SE from three independent experiments. Statistical significance comparing results from cultures of NK cells mixed with purified cytokine-deficient DC subsets to B6 DC subsets is indicated; *<italic>p</italic> &#x0003c;0.05.</p></caption><graphic xlink:href="eji0037-1334-f7"/></fig><p>While conventional DC populations from B6 mice stimulated IFN-&#x003b3; production by &#x0223c;25% of NK cells, pDC obtained from B6 mice potently stimulated IFN-&#x003b3; production by NK cells with &#x0223c;73% of NK cells staining positive for IFN-&#x003b3; (<xref ref-type="fig" rid="fig07">Fig. 7D</xref>). The pDC from IL-12-deficient mice stimulated NK cells (&#x0223c;67%) to levels similar to that observed from B6 animals; however, only &#x0223c;19% of NK cells stained positive for IFN-&#x003b3; after coculture with IL-18-deficient pDC. Thus, in the presence of HSV-1, conventional DC were able to promote IFN-&#x003b3; production by NK cells <italic>via</italic> an IL-18-independent mechanism. In contrast, the potent ability of pDC to induce IFN-&#x003b3; production required the presence of IL-18.</p></sec></sec><sec><title>Discussion</title><p>The secretion of IFN-&#x003b3; by NK cells following viral infection is thought to be an important mechanism for limiting the spread of virus prior to the development of adaptive immunity <xref ref-type="bibr" rid="b4">4</xref>. Moreover, recent evidence suggests that IFN-&#x003b3; expression by NK cells may also be important in the maturation of DC and the induction of a Th1 type response by CD4<sup>+</sup> T lymphocytes <xref ref-type="bibr" rid="b42">42</xref>, <xref ref-type="bibr" rid="b43">43</xref>. However, the mechanisms by which viral infections induce early IFN-&#x003b3; production from NK cells are incompletely understood. We have shown that a direct interaction between HSV-1 and NK cells was insufficient to stimulate the rapid production of IFN-&#x003b3;. Instead, IFN-&#x003b3; synthesis by NK cells following HSV-1 infection involved regulation by other cell types such as DC or macrophages that could serve as a source of IL-18.</p><p>As depletion of DC from <italic>in vitro</italic> splenocyte cultures only partially inhibited NK cell activation, other cells also appear to mediate this function. Consistent with this, removal of F4/80<sup>+</sup> cells together with CD11c<sup>+</sup> cells almost totally abrogated the ability of HSV-1 to induce IFN-&#x003b3; production by NK cells (data not shown), suggesting that DC together with macrophages play a key role in the HSV-1-induced stimulation of NK cells. Critically both DC and macrophages have been shown to express IL-18 <xref ref-type="bibr" rid="b6">6</xref>, <xref ref-type="bibr" rid="b20">20</xref>, <xref ref-type="bibr" rid="b21">21</xref>, which has a major role in augmenting the IFN-&#x003b3; response to HSV-1 by NK cells. Pro-IL-18 is stored in preformed granules within the cytoplasm of cells such as DC or macrophages, and thus may be rapidly converted to its bioactive form <xref ref-type="bibr" rid="b17">17</xref>&#x02013;<xref ref-type="bibr" rid="b19">19</xref>, which may account for its dominant role during the initial stages of HSV-1 infection.</p><p>IL-18 has been shown to augment IFN-&#x003b3; responses by NK cells acting in concert with other cytokines such as type I interferons (IFN-&#x003b1;/&#x003b2;) <xref ref-type="bibr" rid="b44">44</xref>, IL-15, IL-21 <xref ref-type="bibr" rid="b45">45</xref> and in particular, IL-12 <xref ref-type="bibr" rid="b28">28</xref>&#x02013;<xref ref-type="bibr" rid="b30">30</xref>. The synergistic action of IL-18 in enhancing IL-12-dependent IFN-&#x003b3; production by NK cells in the spleen has also been described following systemic MCMV infection in mice <xref ref-type="bibr" rid="b34">34</xref>. However, the production of IFN-&#x003b3; by NK cells following with HSV-1 infection did not require IL-12, but was largely dependent on IL-18.</p><p>Early studies examining cross talk between NK cells and DC identified a role for cell-to-cell contact <xref ref-type="bibr" rid="b42">42</xref>, <xref ref-type="bibr" rid="b46">46</xref>&#x02013;<xref ref-type="bibr" rid="b48">48</xref>. However the mechanisms underpinning the recognition of pathogens and the subsequent induction of innate immune responses by the various lineages of DC is increasingly complex <xref ref-type="bibr" rid="b49">49</xref>. There appears a degree of specialisation in the cytokine responses of particular DC subsets following infection. Following stimulation with HSV-1 or MCMV, pDC produce large quantities of IFN-&#x003b1;/&#x003b2; and IL-12 and hence are thought to be important regulators of NK cells <xref ref-type="bibr" rid="b15">15</xref>, <xref ref-type="bibr" rid="b16">16</xref>. Consistent with this, pDC purified from MCMV-infected mice have been shown to induce both IFN-&#x003b3; production and cytotoxicity by na&#x000ef;e NK cells <xref ref-type="bibr" rid="b40">40</xref>. We demonstrated that pDC exposed to HSV-1 also efficiently stimulated IFN-&#x003b3; production by NK cells. Moreover, while the ability of pDC to potently stimulate NK cells has been proposed to result from the high levels of IFN-&#x003b1;/&#x003b2; and IL-12 secreted following viral infection, we define a role for IL-18 in this process. Semino <italic>et al.</italic><xref ref-type="bibr" rid="b20">20</xref> have demonstrated that IL-18 is largely confined to the synaptic cleft formed between human DC and NK cells, thus creating localised high concentrations of IL-18. Our inability to detect IL-18 in the culture supernatants of HSV-1-stimulated pDC by ELISA (data not shown) may reflect the polarised delivery of IL-18 from DC to NK cells.</p><p>Andoniou <italic>et al</italic><xref ref-type="bibr" rid="b1">7</xref> have shown that activation of NK cells by MCMV-infected bone marrow-derived conventional DC is dependent on IL-18 and to a lesser extent IL-12. In our studies using freshly isolated DC populations exposed to HSV-1, there was no evidence of a role for either IL-18 or IL-12 in the activation of NK cells by conventional DC subsets. This apparent discrepancy may be due to (i) subtle differences in the phenotype and function between bone marrow-derived conventional DC cultured <italic>in vitro</italic> and conventional DC freshly isolated from the spleen and/or (ii) differences in the impact of HSV-1 and MCMV on the function of DC <xref ref-type="bibr" rid="b50">50</xref>, <xref ref-type="bibr" rid="b51">51</xref>. As pathogens have evolved a diverse array of strategies to inactivate DC, the evolution of multiple mechanisms to activate NK cells may be an important adaptation to ensure robust early innate immune responses and may even be critical for the generation of adaptive immunity <italic>via</italic> NK cell mediated maturation of DC.</p><p>Together, the data indicate a role for IL-18 in the activation of NK cells following HSV-1 infection. While it is likely that a number of distinct cell types can mediate this function, the IL-18-dependent activation of NK cells following HSV-1 infection appears to be unique to pDC among splenic DC populations. Moreover, given recent evidence showing that IL-18 induces the expression of CCR7 on human NK cells <xref ref-type="bibr" rid="b52">52</xref>, pDC may induce lymph node homing of NK cells where they can augment the development of subsequent adaptive immune responses <italic>via</italic> the provision of IFN-&#x003b3;.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Mice</title><p>B6 mice, CD45 congeneic B6.SJL-Ptprc<sup>a</sup>Pep3<sup>b</sup>/BoyJ (B6.CD45.1) mice and mice with targeted gene disruptions of <italic>Il-12p40</italic> (B6.IL-12<sup>&#x02013;/&#x02013;</sup>) and <italic>Il-18</italic> (B6.IL-18<sup>&#x02013;/&#x02013;</sup>) were housed in the animal facility of the Department of Microbiology and Immunology, The University of Melbourne (Melbourne, Australia). Male mice were used for experiments at 6 to 10 weeks of age. All experimentation was conducted according to institutional ethical guidelines.</p></sec><sec><title>Virus and cytokines</title><p>HSV-1 (KOS strain) was propagated and titerd on Vero cells. For <italic>in vivo</italic> infections, mice were injected in the tail vein with 10<sup>6</sup> PFU of HSV-1 in 200 &#x003bc;L saline. For mock infections, mice were injected intravenously with a freeze thaw lysate of Vero cells in 200 &#x003bc;L saline. For <italic>in vitro</italic> incubations, splenocytes or purified populations of cells were cultured in 200 &#x003bc;L of RPMI supplemented with 10% heat-inactivated FCS, 23.83 g/L HEPES, 2 mM L-glutamine, 50 &#x003bc;M 2-mercaptoethanol, 100 U/mL of penicillin and 100 &#x003bc;g/mL of streptomycin in Vero cell lysate, HSV-1 or recombinant mouse IL-18 (MBL) for 6 to 8 h in round-bottom 96-well plates (TPP).</p></sec><sec><title>Monoclonal antibodies and flow cytometry</title><p>Single-cell suspensions were incubated in anti-CD16/32 supernatant (2.4G2) and stained with combinations of peridinin chlorophyll protein-Cy5.5, phycoerythrin-, allophycocyanin- (APC) or FITC-conjugated antibodies to CD3&#x003b5; (145&#x02013;2C11), CD8&#x003b1; (53&#x02013;6.7), CD45.1 (A20), CD45RA/B220 (RA3&#x02013;6B2), CD49b (DX5), CD69 (H1.2F3), IFN-&#x003b3; (XMG1.2), NK1.1 (PK136), TCR &#x003b2; chain (H57&#x02013;597, all BD PharMingen) and F4/80 (BM8, Caltag).</p><p>Samples were sorted on MoFlo (DakoCytomation) and FACSAria, acquired on FACSCalibur and LSRII flow cytometers (BD Biosciences) and analysed using FlowJo (Tree Star). Intracellular cytokine staining was performed as described previously <xref ref-type="bibr" rid="b37">37</xref>. For depletion of DC, spleen cells were stained with APC-conjugated streptavidin after incubation in media alone or with biotinylated-anti-CD11c (HL3, BD PharMingen). Cell preparations were then gated on APC-negative splenocytes and purified using cell sorting so that &#x0003c;1% APC-positive cells remained.</p></sec><sec><title><italic>Ex vivo</italic> NK cell cytotoxicity assay</title><p>NK cell cytotoxicity was assayed with a standard chromium release assay using YAC-1 target cells. Percent specific lysis was calculated as 100 &#x000d7; (cpm test sample &#x02013; cpm spontaneous release)/(cpm total release &#x02013; cpm spontaneous release).</p></sec><sec><title>Isolation of NK cells and DC</title><p>NK cells and T cells were isolated to &#x0003e;95% purity by sorting splenocytes labelled with anti-NK1.1-FITC or anti-CD49b-FITC and anti-CD3&#x003b5;-APC. DC were isolated from spleens as previously described <xref ref-type="bibr" rid="b53">53</xref>. Briefly, spleens were mechanically disrupted, digested with collagenase type II (Worthington Biochemicals) and grade II bovine pancreatic DNase I (Boehringer-Mannheim), incubated in EDTA and low-density splenocytes were isolated by centrifugation over a Nycodenz gradient (Axis-Shield). For whole DC isolation, cells were then stained with anti-CD11c-FITC (N418) and anti-F4/80-APC and cell sorted to a purity of &#x0003e;90%. For purification of DC subsets, non-DC lineages were removed by incubating cells with mAb specific for CD3 (KT3), Thy-1 (T24/31.7), CD19 (ID6), Gr-1 (RB6&#x02013;8C5) and erythrocytes (Ter-119), together with sheep anti-rat IgG-coupled magnetic beads (Dynal). Enriched DC were then stained with anti-CD11c, anti-CD8&#x003b1; and anti-CD45RA and sorted by flow cytometry. The purity of DC subsets was typically &#x0003e;95%.</p></sec><sec><title>Statistical analysis</title><p>Two-tailed Student's <italic>t</italic>-test was performed where indicated.</p></sec></sec></body><back><ack><p>The authors wish to thank Professsor Ken Shortman for providing antibodies, Dr. Stephen Turner and staff of the Department of Microbiology and Immunology (The University of Melbourne) and Walter and Eliza Hall Institute of Medical Research flow cytometry facilities for expert technical assistance. We gratefully acknowledge Professor Shizuo Akira, Research Institute for Microbial Diseases (Osaka University) for providing B6.IL-18<sup>&#x02013;/&#x02013;</sup> mice. This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC). G.T.B. is a Wellcome Trust Senior Overseas Research Fellow and a Howard Hughes Medical Institute Scholar. P.C.R. is supported by an NHMRC Career Development Award.</p></ack><ref-list><ref id="b1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>WM</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>French</surname><given-names>AR</given-names></name></person-group><article-title>The dynamic life of natural killer cells</article-title><source>Annu. Rev. Immunol.</source><year>2004</year><volume>22</volume><fpage>405</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">15032583</pub-id></element-citation></ref><ref id="b2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlhofer</surname><given-names>FM</given-names></name><name><surname>Ribaudo</surname><given-names>RK</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><article-title>MHC class I alloantigen specificity of Ly-49<sup>+</sup> IL-2-activated natural killer cells</article-title><source>Nature</source><year>1992</year><volume>358</volume><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">1614533</pub-id></element-citation></ref><ref id="b3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagtmann</surname><given-names>N</given-names></name><name><surname>Biassoni</surname><given-names>R</given-names></name><name><surname>Cantoni</surname><given-names>C</given-names></name><name><surname>Verdiani</surname><given-names>S</given-names></name><name><surname>Malnati</surname><given-names>MS</given-names></name><name><surname>Vitale</surname><given-names>M</given-names></name><name><surname>Bottino</surname><given-names>C</given-names></name><etal/></person-group><article-title>Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains</article-title><source>Immunity</source><year>1995</year><volume>2</volume><fpage>439</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">7749980</pub-id></element-citation></ref><ref id="b4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biron</surname><given-names>CA</given-names></name><name><surname>Nguyen</surname><given-names>KB</given-names></name><name><surname>Pien</surname><given-names>GC</given-names></name><name><surname>Cousens</surname><given-names>LP</given-names></name><name><surname>Salazar-Mather</surname><given-names>TP</given-names></name></person-group><article-title>Natural killer cells in antiviral defense: function and regulation by innate cytokines</article-title><source>Annu. Rev. Immunol.</source><year>1999</year><volume>17</volume><fpage>189</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">10358757</pub-id></element-citation></ref><ref id="b5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Fitz</surname><given-names>L</given-names></name><name><surname>Ryan</surname><given-names>M</given-names></name><name><surname>Hewick</surname><given-names>RM</given-names></name><name><surname>Clark</surname><given-names>SC</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name><name><surname>Loudon</surname><given-names>R</given-names></name><etal/></person-group><article-title>Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes</article-title><source>J. Exp. Med.</source><year>1989</year><volume>170</volume><fpage>827</fpage><lpage>845</lpage><pub-id pub-id-type="pmid">2504877</pub-id></element-citation></ref><ref id="b6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamura</surname><given-names>H</given-names></name><name><surname>Tsutsi</surname><given-names>H</given-names></name><name><surname>Komatsu</surname><given-names>T</given-names></name><name><surname>Yutsudo</surname><given-names>M</given-names></name><name><surname>Hakura</surname><given-names>A</given-names></name><name><surname>Tanimoto</surname><given-names>T</given-names></name><name><surname>Torigoe</surname><given-names>K</given-names></name><etal/></person-group><article-title>Cloning of a new cytokine that induces IFN-gamma production by T cells</article-title><source>Nature</source><year>1995</year><volume>378</volume><fpage>88</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">7477296</pub-id></element-citation></ref><ref id="b7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andoniou</surname><given-names>CE</given-names></name><name><surname>van Dommelen</surname><given-names>SL</given-names></name><name><surname>Voigt</surname><given-names>V</given-names></name><name><surname>Andrews</surname><given-names>DM</given-names></name><name><surname>Brizard</surname><given-names>G</given-names></name><name><surname>Asselin-Paturel</surname><given-names>C</given-names></name><name><surname>Delale</surname><given-names>T</given-names></name><etal/></person-group><article-title>Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity</article-title><source>Nat. Immunol.</source><year>2005</year><volume>6</volume><fpage>1011</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">16142239</pub-id></element-citation></ref><ref id="b8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barchet</surname><given-names>W</given-names></name><name><surname>Krug</surname><given-names>A</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Newby</surname><given-names>C</given-names></name><name><surname>Fischer</surname><given-names>JA</given-names></name><name><surname>Dzionek</surname><given-names>A</given-names></name><name><surname>Pekosz</surname><given-names>A</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group><article-title>Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways</article-title><source>Eur. J. Immunol.</source><year>2005</year><volume>35</volume><fpage>236</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">15593126</pub-id></element-citation></ref><ref id="b9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Andrea</surname><given-names>A</given-names></name><name><surname>Rengaraju</surname><given-names>M</given-names></name><name><surname>Valiante</surname><given-names>NM</given-names></name><name><surname>Chehimi</surname><given-names>J</given-names></name><name><surname>Kubin</surname><given-names>M</given-names></name><name><surname>Aste</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells</article-title><source>J. Exp. Med.</source><year>1992</year><volume>176</volume><fpage>1387</fpage><lpage>1398</lpage><pub-id pub-id-type="pmid">1357073</pub-id></element-citation></ref><ref id="b10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmi</surname><given-names>H</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Kaisho</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Sanjo</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><etal/></person-group><article-title>A Toll-like receptor recognizes bacterial DNA</article-title><source>Nature</source><year>2000</year><volume>408</volume><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">11130078</pub-id></element-citation></ref><ref id="b11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shortman</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name></person-group><article-title>Mouse and human dendritic cell subtypes</article-title><source>Nat. Rev. Immuno.l</source><year>2002</year><volume>2</volume><fpage>151</fpage><lpage>161</lpage></element-citation></ref><ref id="b12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asselin-Paturel</surname><given-names>C</given-names></name><name><surname>Boonstra</surname><given-names>A</given-names></name><name><surname>Dalod</surname><given-names>M</given-names></name><name><surname>Durand</surname><given-names>I</given-names></name><name><surname>Yessaad</surname><given-names>N</given-names></name><name><surname>Dezutter-Dambuyant</surname><given-names>C</given-names></name><name><surname>Vicari</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology</article-title><source>Nat. Immunol.</source><year>2001</year><volume>2</volume><fpage>1144</fpage><lpage>1150</lpage><pub-id pub-id-type="pmid">11713464</pub-id></element-citation></ref><ref id="b13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalod</surname><given-names>M</given-names></name><name><surname>Salazar-Mather</surname><given-names>TP</given-names></name><name><surname>Malmgaard</surname><given-names>L</given-names></name><name><surname>Lewis</surname><given-names>C</given-names></name><name><surname>Asselin-Paturel</surname><given-names>C</given-names></name><name><surname>Briere</surname><given-names>F</given-names></name><name><surname>Trinchieri</surname><given-names>G</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name></person-group><article-title>Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression <italic>in vivo</italic></article-title><source>J. Exp. Med.</source><year>2002</year><volume>195</volume><fpage>517</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">11854364</pub-id></element-citation></ref><ref id="b14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochrein</surname><given-names>H</given-names></name><name><surname>Shortman</surname><given-names>K</given-names></name><name><surname>Vremec</surname><given-names>D</given-names></name><name><surname>Scott</surname><given-names>B</given-names></name><name><surname>Hertzog</surname><given-names>P</given-names></name><name><surname>O'Keeffe</surname><given-names>M</given-names></name></person-group><article-title>Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets</article-title><source>J. Immunol.</source><year>2001</year><volume>166</volume><fpage>5448</fpage><lpage>5455</lpage><pub-id pub-id-type="pmid">11313382</pub-id></element-citation></ref><ref id="b15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krug</surname><given-names>A</given-names></name><name><surname>French</surname><given-names>AR</given-names></name><name><surname>Barchet</surname><given-names>W</given-names></name><name><surname>Fischer</surname><given-names>JA</given-names></name><name><surname>Dzionek</surname><given-names>A</given-names></name><name><surname>Pingel</surname><given-names>JT</given-names></name><name><surname>Orihuela</surname><given-names>MM</given-names></name><etal/></person-group><article-title>TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function</article-title><source>Immunity</source><year>2004</year><volume>21</volume><fpage>107</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">15345224</pub-id></element-citation></ref><ref id="b16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krug</surname><given-names>A</given-names></name><name><surname>Luker</surname><given-names>GD</given-names></name><name><surname>Barchet</surname><given-names>W</given-names></name><name><surname>Leib</surname><given-names>DA</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group><article-title>Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>1433</fpage><lpage>1437</lpage><pub-id pub-id-type="pmid">14563635</pub-id></element-citation></ref><ref id="b17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghayur</surname><given-names>T</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Hugunin</surname><given-names>M</given-names></name><name><surname>Butler</surname><given-names>D</given-names></name><name><surname>Herzog</surname><given-names>L</given-names></name><name><surname>Carter</surname><given-names>A</given-names></name><name><surname>Quintal</surname><given-names>L</given-names></name><etal/></person-group><article-title>Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production</article-title><source>Nature</source><year>1997</year><volume>386</volume><fpage>619</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">9121587</pub-id></element-citation></ref><ref id="b18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Kuida</surname><given-names>K</given-names></name><name><surname>Tsutsui</surname><given-names>H</given-names></name><name><surname>Ku</surname><given-names>G</given-names></name><name><surname>Hsiao</surname><given-names>K</given-names></name><name><surname>Fleming</surname><given-names>MA</given-names></name><name><surname>Hayashi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme</article-title><source>Science</source><year>1997</year><volume>275</volume><fpage>206</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">8999548</pub-id></element-citation></ref><ref id="b19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardella</surname><given-names>S</given-names></name><name><surname>Andrei</surname><given-names>C</given-names></name><name><surname>Poggi</surname><given-names>A</given-names></name><name><surname>Zocchi</surname><given-names>MR</given-names></name><name><surname>Rubartelli</surname><given-names>A</given-names></name></person-group><article-title>Control of interleukin-18 secretion by dendritic cells: role of calcium influxes</article-title><source>FEBS Lett.</source><year>2000</year><volume>481</volume><fpage>245</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">11007972</pub-id></element-citation></ref><ref id="b20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semino</surname><given-names>C</given-names></name><name><surname>Angelini</surname><given-names>G</given-names></name><name><surname>Poggi</surname><given-names>A</given-names></name><name><surname>Rubartelli</surname><given-names>A</given-names></name></person-group><article-title>NK/iDC interaction results in IL-18 secretion by DC at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1</article-title><source>Blood</source><year>2005</year><volume>106</volume><fpage>609</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">15802534</pub-id></element-citation></ref><ref id="b21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>S</given-names></name><name><surname>Jonuleit</surname><given-names>H</given-names></name><name><surname>Schmitt</surname><given-names>E</given-names></name><name><surname>Muller</surname><given-names>G</given-names></name><name><surname>Yamauchi</surname><given-names>H</given-names></name><name><surname>Kurimoto</surname><given-names>M</given-names></name><name><surname>Knop</surname><given-names>J</given-names></name><name><surname>Enk</surname><given-names>AH</given-names></name></person-group><article-title>Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development</article-title><source>Eur. J. Immunol.</source><year>1998</year><volume>28</volume><fpage>3231</fpage><lpage>3239</lpage><pub-id pub-id-type="pmid">9808192</pub-id></element-citation></ref><ref id="b22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conti</surname><given-names>B</given-names></name><name><surname>Park</surname><given-names>LC</given-names></name><name><surname>Calingasan</surname><given-names>NY</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Bae</surname><given-names>Y</given-names></name><name><surname>Gibson</surname><given-names>GE</given-names></name><name><surname>Joh</surname><given-names>TH</given-names></name></person-group><article-title>Cultures of astrocytes and microglia express interleukin 18</article-title><source>Brain Res. Mol. Brain Res.</source><year>1999</year><volume>67</volume><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">10101231</pub-id></element-citation></ref><ref id="b23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>S</given-names></name><name><surname>Muller</surname><given-names>G</given-names></name><name><surname>Kurimoto</surname><given-names>M</given-names></name><name><surname>Saloga</surname><given-names>J</given-names></name><name><surname>Tanimoto</surname><given-names>T</given-names></name><name><surname>Yamauchi</surname><given-names>H</given-names></name><name><surname>Okamura</surname><given-names>H</given-names></name><etal/></person-group><article-title>Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes</article-title><source>J. Immunol.</source><year>1997</year><volume>159</volume><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">9200466</pub-id></element-citation></ref><ref id="b24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizarro</surname><given-names>TT</given-names></name><name><surname>Michie</surname><given-names>MH</given-names></name><name><surname>Bentz</surname><given-names>M</given-names></name><name><surname>Woraratanadharm</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>MF</given-names><suffix>Jr.</suffix></name><name><surname>Foley</surname><given-names>E</given-names></name><name><surname>Moskaluk</surname><given-names>CA</given-names></name><etal/></person-group><article-title>IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells</article-title><source>J. Immunol.</source><year>1999</year><volume>162</volume><fpage>6829</fpage><lpage>6835</lpage><pub-id pub-id-type="pmid">10352304</pub-id></element-citation></ref><ref id="b25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>IS</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Jenkins</surname><given-names>JR</given-names></name><name><surname>Trayhurn</surname><given-names>P</given-names></name></person-group><article-title>The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFalpha in human adipocytes</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2005</year><volume>337</volume><fpage>422</fpage><lpage>429</lpage><pub-id pub-id-type="pmid">16188228</pub-id></element-citation></ref><ref id="b26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conti</surname><given-names>B</given-names></name><name><surname>Jahng</surname><given-names>JW</given-names></name><name><surname>Tinti</surname><given-names>C</given-names></name><name><surname>Son</surname><given-names>JH</given-names></name><name><surname>Joh</surname><given-names>TH</given-names></name></person-group><article-title>Induction of interferon-gamma inducing factor in the adrenal cortex</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>2035</fpage><lpage>2037</lpage><pub-id pub-id-type="pmid">8999896</pub-id></element-citation></ref><ref id="b27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewins</surname><given-names>P</given-names></name><name><surname>Morgan</surname><given-names>MD</given-names></name><name><surname>Holden</surname><given-names>N</given-names></name><name><surname>Neil</surname><given-names>D</given-names></name><name><surname>Williams</surname><given-names>JM</given-names></name><name><surname>Savage</surname><given-names>CO</given-names></name><name><surname>Harper</surname><given-names>L</given-names></name></person-group><article-title>IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis</article-title><source>Kidney Int.</source><year>2006</year><volume>69</volume><fpage>605</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">16514436</pub-id></element-citation></ref><ref id="b28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>CA</given-names></name><name><surname>Timans</surname><given-names>J</given-names></name><name><surname>Pisacane</surname><given-names>P</given-names></name><name><surname>Menon</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name><name><surname>Walker</surname><given-names>W</given-names></name><name><surname>Aste-Amezaga</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer</article-title><source>Eur. J. Immunol.</source><year>1997</year><volume>27</volume><fpage>2787</fpage><lpage>2792</lpage><pub-id pub-id-type="pmid">9394800</pub-id></element-citation></ref><ref id="b29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matikainen</surname><given-names>S</given-names></name><name><surname>Paananen</surname><given-names>A</given-names></name><name><surname>Miettinen</surname><given-names>M</given-names></name><name><surname>Kurimoto</surname><given-names>M</given-names></name><name><surname>Timonen</surname><given-names>T</given-names></name><name><surname>Julkunen</surname><given-names>I</given-names></name><name><surname>Sareneva</surname><given-names>T</given-names></name></person-group><article-title>IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12</article-title><source>Eur. J. Immunol.</source><year>2001</year><volume>31</volume><fpage>2236</fpage><lpage>2245</lpage><pub-id pub-id-type="pmid">11449378</pub-id></element-citation></ref><ref id="b30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomura</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>XY</given-names></name><name><surname>Maruo</surname><given-names>S</given-names></name><name><surname>Ahn</surname><given-names>HJ</given-names></name><name><surname>Hamaoka</surname><given-names>T</given-names></name><name><surname>Okamura</surname><given-names>H</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><etal/></person-group><article-title>A critical role for IL-18 in the proliferation and activation of NK1.1<sup>+</sup> CD3<sup>&#x02013;</sup> cells</article-title><source>J. Immunol.</source><year>1998</year><volume>160</volume><fpage>4738</fpage><lpage>4746</lpage><pub-id pub-id-type="pmid">9590219</pub-id></element-citation></ref><ref id="b31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gracie</surname><given-names>JA</given-names></name><name><surname>Robertson</surname><given-names>SE</given-names></name><name><surname>McInnes</surname><given-names>IB</given-names></name></person-group><article-title>Interleukin-18</article-title><source>J. Leukoc. Biol.</source><year>2003</year><volume>73</volume><fpage>213</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">12554798</pub-id></element-citation></ref><ref id="b32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group><article-title>Interleukin-12: a cytokine at the interface of inflammation and immunity</article-title><source>Adv. Immunol.</source><year>1998</year><volume>70</volume><fpage>83</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">9755338</pub-id></element-citation></ref><ref id="b33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauw</surname><given-names>FN</given-names></name><name><surname>Branger</surname><given-names>J</given-names></name><name><surname>Florquin</surname><given-names>S</given-names></name><name><surname>Speelman</surname><given-names>P</given-names></name><name><surname>van Deventer</surname><given-names>SJ</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><article-title>IL-18 improves the early antimicrobial host response to pneumococcal pneumonia</article-title><source>J. Immunol.</source><year>2002</year><volume>168</volume><fpage>372</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">11751983</pub-id></element-citation></ref><ref id="b34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pien</surname><given-names>GC</given-names></name><name><surname>Satoskar</surname><given-names>AR</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name></person-group><article-title>Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection</article-title><source>J. Immunol.</source><year>2000</year><volume>165</volume><fpage>4787</fpage><lpage>4791</lpage><pub-id pub-id-type="pmid">11046000</pub-id></element-citation></ref><ref id="b35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habu</surname><given-names>S</given-names></name><name><surname>Akamatsu</surname><given-names>K</given-names></name><name><surname>Tamaoki</surname><given-names>N</given-names></name><name><surname>Okumura</surname><given-names>K</given-names></name></person-group><article-title><italic>In vivo</italic> significance of NK cell on resistance against virus (HSV-1) infections in mice</article-title><source>J. Immunol.</source><year>1984</year><volume>133</volume><fpage>2743</fpage><lpage>2747</lpage><pub-id pub-id-type="pmid">6207244</pub-id></element-citation></ref><ref id="b36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>RA</given-names></name><name><surname>Scalzo</surname><given-names>A</given-names></name><name><surname>Simmons</surname><given-names>A</given-names></name></person-group><article-title>Cutting edge: a NK complex-linked locus governs acute <italic>versus</italic> latent herpes simplex virus infection of neurons</article-title><source>J. Immunol.</source><year>2001</year><volume>166</volume><fpage>5869</fpage><lpage>5873</lpage><pub-id pub-id-type="pmid">11342599</pub-id></element-citation></ref><ref id="b37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reading</surname><given-names>PC</given-names></name><name><surname>Whitney</surname><given-names>PG</given-names></name><name><surname>Barr</surname><given-names>DP</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name><name><surname>Brooks</surname><given-names>AG</given-names></name></person-group><article-title>NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection</article-title><source>Eur. J. Immunol.</source><year>2006</year><volume>36</volume><fpage>897</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">16552715</pub-id></element-citation></ref><ref id="b38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazzinelli</surname><given-names>RT</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Wolf</surname><given-names>S</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group><article-title>Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1993</year><volume>90</volume><fpage>6115</fpage><lpage>6119</lpage><pub-id pub-id-type="pmid">8100999</pub-id></element-citation></ref><ref id="b39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripp</surname><given-names>CS</given-names></name><name><surname>Wolf</surname><given-names>SF</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group><article-title>Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1993</year><volume>90</volume><fpage>3725</fpage><lpage>3729</lpage><pub-id pub-id-type="pmid">8097322</pub-id></element-citation></ref><ref id="b40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalod</surname><given-names>M</given-names></name><name><surname>Hamilton</surname><given-names>T</given-names></name><name><surname>Salomon</surname><given-names>R</given-names></name><name><surname>Salazar-Mather</surname><given-names>TP</given-names></name><name><surname>Henry</surname><given-names>SC</given-names></name><name><surname>Hamilton</surname><given-names>JD</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name></person-group><article-title>Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta</article-title><source>J. Exp. Med.</source><year>2003</year><volume>197</volume><fpage>885</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">12682109</pub-id></element-citation></ref><ref id="b41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timonen</surname><given-names>T</given-names></name><name><surname>Patarroyo</surname><given-names>M</given-names></name><name><surname>Gahmberg</surname><given-names>CG</given-names></name></person-group><article-title>CD11a-c/CD18 and GP84 (LB-2) adhesion molecules on human large granular lymphocytes and their participation in natural killing</article-title><source>J. Immunol.</source><year>1988</year><volume>141</volume><fpage>1041</fpage><lpage>1046</lpage><pub-id pub-id-type="pmid">2899596</pub-id></element-citation></ref><ref id="b42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerosa</surname><given-names>F</given-names></name><name><surname>Baldani-Guerra</surname><given-names>B</given-names></name><name><surname>Nisii</surname><given-names>C</given-names></name><name><surname>Marchesini</surname><given-names>V</given-names></name><name><surname>Carra</surname><given-names>G</given-names></name><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group><article-title>Reciprocal activating interaction between natural killer cells and dendritic cells</article-title><source>J. Exp. Med.</source><year>2002</year><volume>195</volume><fpage>327</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">11828007</pub-id></element-citation></ref><ref id="b43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Fontecha</surname><given-names>A</given-names></name><name><surname>Thomsen</surname><given-names>LL</given-names></name><name><surname>Brett</surname><given-names>S</given-names></name><name><surname>Gerard</surname><given-names>C</given-names></name><name><surname>Lipp</surname><given-names>M</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name><name><surname>Sallusto</surname><given-names>F</given-names></name></person-group><article-title>Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming</article-title><source>Nat. Immunol.</source><year>2004</year><volume>5</volume><fpage>1260</fpage><lpage>1265</lpage><pub-id pub-id-type="pmid">15531883</pub-id></element-citation></ref><ref id="b44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sareneva</surname><given-names>T</given-names></name><name><surname>Matikainen</surname><given-names>S</given-names></name><name><surname>Kurimoto</surname><given-names>M</given-names></name><name><surname>Julkunen</surname><given-names>I</given-names></name></person-group><article-title>Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells</article-title><source>J. Immunol.</source><year>1998</year><volume>160</volume><fpage>6032</fpage><lpage>6038</lpage><pub-id pub-id-type="pmid">9637519</pub-id></element-citation></ref><ref id="b45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strengell</surname><given-names>M</given-names></name><name><surname>Matikainen</surname><given-names>S</given-names></name><name><surname>Siren</surname><given-names>J</given-names></name><name><surname>Lehtonen</surname><given-names>A</given-names></name><name><surname>Foster</surname><given-names>D</given-names></name><name><surname>Julkunen</surname><given-names>I</given-names></name><name><surname>Sareneva</surname><given-names>T</given-names></name></person-group><article-title>IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells</article-title><source>J. Immunol.</source><year>2003</year><volume>170</volume><fpage>5464</fpage><lpage>5469</lpage><pub-id pub-id-type="pmid">12759422</pub-id></element-citation></ref><ref id="b46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferlazzo</surname><given-names>G</given-names></name><name><surname>Tsang</surname><given-names>ML</given-names></name><name><surname>Moretta</surname><given-names>L</given-names></name><name><surname>Melioli</surname><given-names>G</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name><name><surname>Munz</surname><given-names>C</given-names></name></person-group><article-title>Human dendritic cells activate resting natural killer (NK) cells and are recognized <italic>via</italic> the NKp30 receptor by activated NK cells</article-title><source>J. Exp. Med.</source><year>2002</year><volume>195</volume><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="pmid">11828009</pub-id></element-citation></ref><ref id="b47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>NC</given-names></name><name><surname>Lozier</surname><given-names>A</given-names></name><name><surname>Flament</surname><given-names>C</given-names></name><name><surname>Ricciardi-Castagnoli</surname><given-names>P</given-names></name><name><surname>Bellet</surname><given-names>D</given-names></name><name><surname>Suter</surname><given-names>M</given-names></name><name><surname>Perricaudet</surname><given-names>M</given-names></name><etal/></person-group><article-title>Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses <italic>in vivo</italic></article-title><source>Nat. Med.</source><year>1999</year><volume>5</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">10202929</pub-id></element-citation></ref><ref id="b48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccioli</surname><given-names>D</given-names></name><name><surname>Sbrana</surname><given-names>S</given-names></name><name><surname>Melandri</surname><given-names>E</given-names></name><name><surname>Valiante</surname><given-names>NM</given-names></name></person-group><article-title>Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells</article-title><source>J. Exp. Med.</source><year>2002</year><volume>195</volume><fpage>335</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">11828008</pub-id></element-citation></ref><ref id="b49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name></person-group><article-title>Close encounters of different kinds: dendritic cells and NK cells take centre stage</article-title><source>Nat. Rev. Immunol.</source><year>2005</year><volume>5</volume><fpage>112</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">15688039</pub-id></element-citation></ref><ref id="b50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>DM</given-names></name><name><surname>Andoniou</surname><given-names>CE</given-names></name><name><surname>Granucci</surname><given-names>F</given-names></name><name><surname>Ricciardi-Castagnoli</surname><given-names>P</given-names></name><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name></person-group><article-title>Infection of dendritic cells by murine cytomegalovirus induces functional paralysis</article-title><source>Nat. Immunol.</source><year>2001</year><volume>2</volume><fpage>1077</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">11668340</pub-id></element-citation></ref><ref id="b51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>CA</given-names></name><name><surname>Fernandez</surname><given-names>M</given-names></name><name><surname>Herc</surname><given-names>K</given-names></name><name><surname>Bosnjak</surname><given-names>L</given-names></name><name><surname>Miranda-Saksena</surname><given-names>M</given-names></name><name><surname>Boadle</surname><given-names>RA</given-names></name><name><surname>Cunningham</surname><given-names>A</given-names></name></person-group><article-title>Herpes simplex virus type 2 induces rapid cell death and functional impairment of murine dendritic cells <italic>in vitro</italic></article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>11139</fpage><lpage>11149</lpage><pub-id pub-id-type="pmid">14512561</pub-id></element-citation></ref><ref id="b52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mailliard</surname><given-names>RB</given-names></name><name><surname>Alber</surname><given-names>SM</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Watkins</surname><given-names>SC</given-names></name><name><surname>Kirkwood</surname><given-names>JM</given-names></name><name><surname>Herberman</surname><given-names>RB</given-names></name><name><surname>Kalinski</surname><given-names>P</given-names></name></person-group><article-title>IL-18-induced CD83<sup>+</sup>CCR7<sup>+</sup> NK helper cells</article-title><source>J. Exp. Med.</source><year>2005</year><volume>202</volume><fpage>941</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">16203865</pub-id></element-citation></ref><ref id="b53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vremec</surname><given-names>D</given-names></name><name><surname>Pooley</surname><given-names>J</given-names></name><name><surname>Hochrein</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Shortman</surname><given-names>K</given-names></name></person-group><article-title>CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen</article-title><source>J. Immunol.</source><year>2000</year><volume>164</volume><fpage>2978</fpage><lpage>2986</lpage><pub-id pub-id-type="pmid">10706685</pub-id></element-citation></ref></ref-list><glossary><def-list><title>Abbreviations:</title><def-item><term>APC:</term><def><p>allophycocyanin</p></def></def-item><def-item><term>B6:</term><def><p>C57BL/6</p></def></def-item><def-item><term>MCMV:</term><def><p>murine cytomegalovirus</p></def></def-item><def-item><term>pDC:</term><def><p>plasmacytoid DC</p></def></def-item></def-list></glossary></back></article>